All In Biotech

Drug Trial Radar · NCT07170150

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)

Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,060 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,060

Actual

Start

Nov 12, 2025

Primary completion

Feb 16, 2028

Study completion Feb 16, 2028

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Sep 12, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to mild dementia due to AD).

Conditions

  • Alzheimers Disease

Interventions

  • TrontinemabDrug

    Participants will receive IV trontinemab

  • PlaceboOther

    Participants will receive IV placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 72 in Clinical Dementia Rating, Sum of Boxes (CDR-SB)Time frame: Baseline - Week 72

Locations

147 sites in 16 countries. Site status is shown where the registry gives one.

  • Banner Alzheimer?s Institute

    Phoenix, Arizona

  • Sun Valley Research Center, Inc.

    Imperial, California

  • Healthy Brain Clinic

    Long Beach, California

  • Oakland Clinical

    Oakland, California

  • Riverside Clinical

    Riverside, California

  • Cenexel California Neuroscience Research, LLC

    Sherman Oaks, California

  • Yale University

    New Haven, Connecticut

  • JEM Research LLC

    Atlantis, Florida

  • K2 Medical Research-Winter Garden

    Clermont, Florida

  • Visionary Investigators Network- Neurology Aventura

    Miami, Florida

  • Charter Research - Winter Park/Orlando

    Orlando, Florida

  • Conquest Research - Lake Nona

    Orlando, Florida

  • Alzheimer's Research and Treatment Center

    Stuart, Florida

  • CenExel iResearch, LLC

    Decatur, Georgia

  • Center for Advanced Research & Education

    Gainesville, Georgia

  • Great Lakes Clinical Trials Chicago d/b/a Flourish Research Andersonville

    Chicago, Illinois

  • Adams Clinical Boston

    Boston, Massachusetts

  • Adams Clinical Watertown

    Watertown, Massachusetts

  • Quest Research Institute

    Farmington Hills, Michigan

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • The Cognitive and Research Center of New Jersey

    Springfield, New Jersey

  • IMA Clinical Research - Albuquerque

    Albuquerque, New Mexico

  • AD-CARE, University of Rochester Medical Center

    Rochester, New York

  • Summit Research Network Inc.

    Portland, Oregon

  • Flourish Research ? Philadelphia

    Plymouth Meeting, Pennsylvania

  • Palmetto Clinical Trials

    Summerville, South Carolina

  • Gadolin Research, LLC

    Beaumont, Texas

  • Kerwin Medical Center

    Dallas, Texas

  • Re:Cognition Health - Fort Worth

    Fort Worth, Texas

  • Mt.Olympus Medical Research

    Katy, Texas

  • El Faro Health and Therapeutics

    Rio Grande City, Texas

  • Sana Research, LLC

    Arlington, Virginia

  • Re:Cognition Health

    Fairfax, Virginia

  • CIER

    C. A. B. A., Argentina

  • Fundacion Scherbovsky

    Mendoza, Argentina

  • INECO Neurociencias Orono

    Rosario, Santa Fe Province, Argentina

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia

  • Southern Neurology

    Kogarah, New South Wales, Australia

  • KaRa Institute of Neurological Diseases

    Macquarie Park, New South Wales, Australia

  • Flinders Medical Centre

    Bedford Park, South Australia, Australia

Showing 40 of 147 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.